Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omega 3 Fish Oil in NASH
NCT00681408Phase 3Completed
- Sponsor
- University of Virginia
- Start
- Mar 2007
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of omega-3-acid triglycerides in Nonalcoholic steatohepatitis (NASH), sponsored by University of Virginia. Primary endpoint: NASH Activity Score at 12 months. Started Mar 2007; status: completed.
02
Drugs
omega-3-acid triglycerides
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT00681408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00681408.